Travere Therapeutics (TVTX) Inventory (2014 - 2026)
Travere Therapeutics posted quarterly Inventory of $6.4 million for Q1 2026, up 61.65% year-on-year from $3.9 million in Q1 2025, and up 8.19% on a QoQ basis from $5.9 million in Q4 2025.
Travere Therapeutics (TVTX) has 13 years of Inventory data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 61.65% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 61.65% YoY), and the FY2025 full-year result was $5.9 million, down 5.24% from the prior year.
- Inventory for Q1 2026 stood at $6.4 million, up from $5.9 million in the prior quarter.
- Across five years, Inventory topped out at $20.8 million in Q3 2023 and bottomed at $3.9 million in Q1 2025.
- The 5-year median for Inventory is $6.4 million (2024), against an average of $7.7 million.
- The widest annual swing landed in 2023, when Inventory jumped 184.68%; it then plunged 69.4% in 2024.
- A 5-year view of Inventory shows it stood at $4.5 million in 2022, then surged by 108.05% to $9.4 million in 2023, then slumped by 34.11% to $6.2 million in 2024, then slipped by 5.24% to $5.9 million in 2025, then increased by 8.19% to $6.4 million in 2026.
- The last three Inventory figures came in at $6.4 million (Q1 2026), $5.9 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn | 6.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 4.09 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 5.98 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 9.41 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 18.77 Mn |
| Mar 31, 2023 | 6.71 Mn |
| Dec 31, 2022 | 4.52 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 7.63 Mn |
| Mar 31, 2022 | 6.52 Mn |
| Dec 31, 2021 | 7.31 Mn |
| Sep 30, 2021 | 6.62 Mn |
| Jun 30, 2021 | 7.41 Mn |
| Mar 31, 2021 | 7.18 Mn |
| Dec 31, 2020 | 7.61 Mn |
| Sep 30, 2020 | 7.26 Mn |
| Jun 30, 2020 | 6.29 Mn |
| Mar 31, 2020 | 6.59 Mn |
| Dec 31, 2019 | 6.08 Mn |
| Sep 30, 2019 | 5.26 Mn |
| Jun 30, 2019 | 5.05 Mn |
| Mar 31, 2019 | 5.57 Mn |
| Dec 31, 2018 | 5.62 Mn |
| Sep 30, 2018 | 5.13 Mn |
| Jun 30, 2018 | 5.39 Mn |
| Mar 31, 2018 | 5.14 Mn |
| Dec 31, 2017 | 5.35 Mn |
| Sep 30, 2017 | 4.32 Mn |
| Jun 30, 2017 | 4.37 Mn |
| Mar 31, 2017 | 4.75 Mn |
| Dec 31, 2016 | 2.83 Mn |
| Sep 30, 2016 | 3.25 Mn |
| Jun 30, 2016 | 2.71 Mn |
| Mar 31, 2016 | 3.23 Mn |
| Dec 31, 2015 | 2.54 Mn |
| Sep 30, 2015 | 2.65 Mn |
| Jun 30, 2015 | 2.01 Mn |
| Mar 31, 2015 | 1.72 Mn |
| Dec 31, 2014 | 801,000.00 |
| Sep 30, 2014 | 683,565.00 |